Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 32125 | 112 | 44.8 | 94% |
Classes in level above (level 2) |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | SESTRIN 2 | Author keyword | 10 | 73% | 7% | 8 |
| 2 | TP53INP1 | Author keyword | 4 | 39% | 8% | 9 |
| 3 | SESTRIN | Author keyword | 4 | 46% | 5% | 6 |
| 4 | MRC GHF | Address | 3 | 50% | 4% | 4 |
| 5 | SESN2 | Author keyword | 2 | 67% | 2% | 2 |
| 6 | TP53INP2 | Author keyword | 1 | 50% | 2% | 2 |
| 7 | SESTRIN2 | Author keyword | 1 | 33% | 3% | 3 |
| 8 | SESTRINS | Author keyword | 1 | 40% | 2% | 2 |
| 9 | EMI 0116 | Address | 1 | 22% | 4% | 4 |
| 10 | ST S CELLULAIRE U624 | Address | 1 | 20% | 4% | 4 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | SESTRIN 2 | 10 | 73% | 7% | 8 | Search SESTRIN+2 | Search SESTRIN+2 |
| 2 | TP53INP1 | 4 | 39% | 8% | 9 | Search TP53INP1 | Search TP53INP1 |
| 3 | SESTRIN | 4 | 46% | 5% | 6 | Search SESTRIN | Search SESTRIN |
| 4 | SESN2 | 2 | 67% | 2% | 2 | Search SESN2 | Search SESN2 |
| 5 | TP53INP2 | 1 | 50% | 2% | 2 | Search TP53INP2 | Search TP53INP2 |
| 6 | SESTRIN2 | 1 | 33% | 3% | 3 | Search SESTRIN2 | Search SESTRIN2 |
| 7 | SESTRINS | 1 | 40% | 2% | 2 | Search SESTRINS | Search SESTRINS |
| 8 | 6Q21 | 1 | 50% | 1% | 1 | Search 6Q21 | Search 6Q21 |
| 9 | ARG8 | 1 | 50% | 1% | 1 | Search ARG8 | Search ARG8 |
| 10 | SERUM REGULATION | 1 | 50% | 1% | 1 | Search SERUM+REGULATION | Search SERUM+REGULATION |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | INDUCED PROTEIN SIP | 4 | 44% | 6% | 7 |
| 2 | PROTEIN P53 INDUCED NUCLEAR PROTEIN 1 | 2 | 44% | 4% | 4 |
| 3 | TUMOR PROTEIN 53 INDUCED NUCLEAR PROTEIN 1 | 1 | 33% | 3% | 3 |
| 4 | P53 INDUCED NUCLEAR PROTEIN 1 | 1 | 33% | 2% | 2 |
| 5 | ENTEROCOCCUS FAECIUM EF1 | 1 | 50% | 1% | 1 |
| 6 | HUMAN SULFIREDOXIN | 1 | 50% | 1% | 1 |
| 7 | GENE FAD104 | 0 | 33% | 1% | 1 |
| 8 | TP53INP1 | 0 | 33% | 1% | 1 |
| 9 | HUMAN ADIPOSE CELLS | 0 | 25% | 1% | 1 |
| 10 | AGING ROS | 0 | 20% | 1% | 1 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Sestrins Orchestrate Cellular Metabolism to Attenuate Aging | 2013 | 15 | 65 | 31% |
| Sestrins: Novel antioxidant and AMPK-modulating functions regulated by exercise? | 2013 | 7 | 41 | 32% |
| Stress-Responsive Sestrins Link p53 with Redox Regulation and Mammalian Target of Rapamycin Signaling | 2011 | 28 | 120 | 12% |
| Stressin' Sestrins take an aging fight | 2010 | 36 | 105 | 13% |
| The dual role of p53: DNA protection and antioxidant | 2011 | 19 | 92 | 10% |
| Cross Talk between Cellular Redox Status, Metabolism, and p53 in Neural Stem Cell Biology | 2014 | 2 | 176 | 6% |
| Cell Cycle Abnormality in Metabolic Syndrome and Nuclear Receptors as an Emerging Therapeutic Target | 2013 | 1 | 27 | 11% |
| Mutant mouse models of oxidative stress | 2010 | 6 | 62 | 10% |
| p53, Oxidative Stress, and Aging | 2011 | 33 | 120 | 3% |
| Guardian of corpulence: a hypothesis on p53 signaling in the fat cell | 2009 | 9 | 128 | 4% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | MRC GHF | 3 | 50% | 3.6% | 4 |
| 2 | EMI 0116 | 1 | 22% | 3.6% | 4 |
| 3 | ST S CELLULAIRE U624 | 1 | 20% | 3.6% | 4 |
| 4 | SECC INVEST POS | 1 | 50% | 0.9% | 1 |
| 5 | JIANGSU PROV HOSP TRADIT CHINESE MED TCM | 0 | 33% | 0.9% | 1 |
| 6 | MOL ONCOL CELL CYCLE REGULAT TRANSLAT | 0 | 33% | 0.9% | 1 |
| 7 | SAMSUNG BIOMED FUTURE MED | 0 | 33% | 0.9% | 1 |
| 8 | U1065C3M | 0 | 33% | 0.9% | 1 |
| 9 | IFR31U858 | 0 | 25% | 0.9% | 1 |
| 10 | RNAI NON CODING RNA | 0 | 25% | 0.9% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000147397 | PEROXIREDOXIN//THIOREDOXIN PEROXIDASE//SULFIREDOXIN |
| 2 | 0.0000091773 | MUTANT P53//GAIN OF FUNCTION//CANC THER EUT S |
| 3 | 0.0000087522 | ROMO1//ANTICANC MOL ONCOL//NOX 1 |
| 4 | 0.0000085231 | NELFINAVIR//SAQUINAVIR NO//ANTIRETROVIRALL THERAPY |
| 5 | 0.0000083028 | FOXO//FOXO3A//FOXO1 |
| 6 | 0.0000079331 | MTOR//RAPAMYCIN//CCI 779 |
| 7 | 0.0000075398 | RARRES3//TIG3//H REV107 |
| 8 | 0.0000073431 | WARBURG EFFECT//PKM2//3 BROMOPYRUVATE |
| 9 | 0.0000070111 | HIPK2//CACYBP SIP//CACYBP |
| 10 | 0.0000069518 | P8//NUPR1//COM 1 |